Global Variation in Lipoprotein(a) Levels Among Patients With Coronary Heart Disease: Insights From the INTERASPIRE Study and Implications for Emerging Lp(a)-Lowering Therapies.
Barkas F, Brandts J, De Bacquer D, Jennings C, De Backer GG, Kotseva K, Ryden L, Lip GYH, Santos RD, Libby P, Erlund I, Ganly S, Vihervaara T, Adamska A, Abreu A, Almahmeed W, Ambari AM, Ge J, Hasan-Ali H, Huo Y, Jankowski P, Jimenez RM, Li Y, Mahmood Zuhdi AS, Makubi A, Mbakwem AC, Mbau L, Navarro Estrada JL, Ogah OS, Ogola EN, Quintero-Baiz A, Sani MU, Sosa Liprandi MI, Tan JWC, Urina Triana MA, Yeo TJ, Wood D, McEvoy JW, Ray KK; INTERASPIRE Investigators.
Barkas F, et al.
J Am Coll Cardiol. 2025 Jun 3;85(21):2028-2042. doi: 10.1016/j.jacc.2025.04.010.
J Am Coll Cardiol. 2025.
PMID: 40436467